Researchers at The Ottawa Hospital and the University of Ottawa
Pfizer Terminates Domagrozumab (PF-06252616) Clinical Studies for the Treatment of Duchenne Muscular Dystrophy
August 30, 2018 – Pfizer Inc. (NYSE: PFE) announced today
allmyfamilycare.com
Researchers at The Ottawa Hospital and the University of Ottawa
August 30, 2018 – Pfizer Inc. (NYSE: PFE) announced today